1. Metformin Prevents Renal Fibrosis in Mice with Unilateral Ureteral Obstruction and Inhibits Ang II-Induced ECM Production in Renal Fibroblasts
   Yang Shen et al, 2016, IJMS CrossRef
2. Fish Oil Feeding Modulates the Expression of Hepatic MicroRNAs in a Western-Style Diet-Induced Nonalcoholic Fatty Liver Disease Rat Model
   Hualin Wang et al, 2017, BioMed Research International CrossRef
3. Identification and characterization of metformin on peptidomic profiling in human visceral adipocytes
   Yao Gao et al, 2017, J Cell Biochem CrossRef
4. Novel roles for LIX1L in promoting cancer cell proliferation through ROS1-mediated LIX1L phosphorylation
   Satoki Nakamura et al, 2015, Sci Rep CrossRef
5. Mechanism of gemcitabine-induced suppression of human cholangiocellular carcinoma cell growth
   YUKA TOYOTA et al, 2015 CrossRef
6. Who watches the watchmen? Regulation of the expression and activity of sirtuins
   Marcin Buler et al, 2016, The FASEB Journal CrossRef
7. Metformin Regulating miR-34a Pathway to Inhibit Egr1 in Rat Mesangial Cells Cultured with High Glucose
   Can Wu et al, 2018, International Journal of Endocrinology CrossRef
8. Epigenetic effects of metformin: From molecular mechanisms to clinical implications
   Stephanie Claire Bridgeman et al, 2018, Diabetes Obes Metab CrossRef
9. To die or not to die: death signaling in nonalcoholic fatty liver disease
   Yuko Akazawa et al, 2018, J Gastroenterol CrossRef
10. TAM 2.0: tool for MicroRNA set analysis
    Jianwei Li et al, 2018 CrossRef
11. Adipocyte alterations in endometriosis: reduced numbers of stem cells and microRNA induced alterations in adipocyte metabolic gene expression
    Masoumeh Majidi Zolbin et al, 2019, Reprod Biol Endocrinol CrossRef
12. Metformin promotes proliferation and suppresses apoptosis in Ox-LDL stimulated macrophages by regulating the miR-34a/Bcl2 axis
    Liuliu Feng et al, 2019, RSC Adv. CrossRef
13. MicroRNA‐223 Ameliorates Nonalcoholic Steatohepatitis and Cancer by Targeting Multiple Inflammatory and Oncogenic Genes in Hepatocytes
    Yong He et al, 2019, Hepatology CrossRef
14. Metformin inhibits high glucose-induced mesangial cell proliferation, inflammation and ECM expression through the SIRT1-FOXO1-autophagy axis.
    Jiang Xu et al, 2019, Clin Exp Pharmacol Physiol CrossRef
15. Role of MicroRNAs in NAFLD/NASH
    Gyongyi Szabo et al, 2016, Dig Dis Sci CrossRef
16. DJ-1 deficiency alleviates steatosis in cultured hepatocytes
    Harmesh N. Chaudhari et al, 2015, Biotechnol Bioproc E CrossRef
17. null
    Ans Jacobs et al, 2016 CrossRef
18. Mechanism of the Hypoglycemic Activity and Hepatoprotective Effect of the Aqueous Extract of Cecropia obtusifolia Bertol
    María de los Ángeles Fortis-Barrera et al, 2019, Journal of Medicinal Food CrossRef
19. Descending Expression of miR320 in Insulin-Resistant Adipocytes Treated with Ascending Concentrations of Metformin
    Yousof Naghiaee et al, 2020, Biochem Genet CrossRef
20. Endothelin-1 promotes epithelial-mesenchymal transition in human chondrosarcoma cells by repressing miR-300
    Min-Huan Wu et al, 2016, Oncotarget CrossRef
21. Metformin-induced suppression of NLK improves erythropoiesis in pre-clinical models of Diamond Blackfan Anemia through induction of miR-26a.
    MC Wilkes et al, 2020, Experimental Hematology CrossRef
22. Metformin downregulates miR223 expression in insulin-resistant 3T3L1 cells and human diabetic adipose tissue
    Yousof Naghiaee et al, 2020, Endocrine CrossRef
23. Autophagy-regulating miRNAs: potential targets for obesity and related metabolic disorders
    Tian Zhang et al, 2021, Drug Discovery Today CrossRef
24. Metformin and insulin-resistant related diseases: Emphasis on the role of microRNAs
    Nahid Alimoradi et al, 2021, Biomedicine & Pharmacotherapy CrossRef
25. Metformin attenuates ischemia/reperfusion-induced apoptosis of cardiac cells by downregulation of p53/microRNA-34a via activation of SIRT1
    Weiwei Li et al, 2021, Can. J. Physiol. Pharmacol. CrossRef
26. Diagnosis and Therapeutic Management of Liver Fibrosis by MicroRNA
    Tomoko Tadokoro et al, 2021, IJMS CrossRef
27. Comparing the Effect of Cinnamaldehyde and Metformin on Expression of MiR320 and MiR26-b in Insulin Resistant 3T3L1 Adipocytes
    Yousof Naghiaee et al, 2021, Phytomedicine Plus CrossRef
28. Foresight regarding drug candidates acting on the succinate–GPR91 signalling pathway for non-alcoholic steatohepatitis (NASH) treatment
    Chengyuan Liang et al, 2021, Biomedicine & Pharmacotherapy CrossRef
29. Updates on Dietary Models of Nonalcoholic Fatty Liver Disease: Current Studies and Insights
    Kristen Stephenson et al, 2018, gene expr CrossRef
30. Role of microRNAs in the process of metformin treating multiple diseases
    Ningning Ma et al, 2021 CrossRef
31. Advances in metformin for the treatment of non-alcoholic fatty liver disease in children
    Qian-Long Wu et al, 2022, Expert Review of Gastroenterology & Hepatology CrossRef
32. Hepatic gene expression and functional changes associated with nonalcoholic steatohepatitis
    Kana Matsumoto et al, 2022, Mol Med Rep CrossRef
33. Research progress of metformin in the treatment of liver fibrosis
    Anqi Zhang et al, 2023, International Immunopharmacology CrossRef
34. Metformin: update on mechanisms of action on liver diseases
    Gaoyi Ruan et al, 2023, Front. Nutr. CrossRef
35. Circulating microRNA expression and nonalcoholic fatty liver disease in adolescents with severe obesity
    Yi-Jie Li et al, 2024, World J Gastroenterol CrossRef
36. Tenascin-X is increased with decreased expression of miR-378a-5p and miR-486-5p in mice fed a methionine-choline-deficient diet that induces hepatic fibrosis
    Ken-ichi MATSUMOTO et al, 2024, Biomed. Res. CrossRef